Skip to content

The Real World Study on Prevention and Treatment of Postoperative Recurrence of Brain Glioma with Integrated Traditional Chinese and Western Medicine

The Real World Study on Prevention and Treatment of Postoperative Recurrence of Brain Glioma with Integrated Traditional Chinese and Western Medicine

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084340
Enrollment
Unknown
Registered
2024-05-14
Start date
2021-12-30
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

Exposure group:On the basis of the STUPP plan, add the formula of tonifying qi, removing blood stasis, and detoxifying
Non exposed group:Simple STUPP scheme

Sponsors

Affiliated Hospital of Shaanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (a) Aged between 18 and 70 years (b) Conform to imaging diagnostic criteria for glioma (c) Pathological diagnosis conforms to the characteristics of glioma, and WHO classification is clear (d) There are obvious signs of intracranial hypertension and cerebral hernia (e) There is neurological dysfunction due to tumor space occupying (f) With or without a clear history of seizures (if one of the items d-f is met, it is OK) (g) Those who voluntarily receive traditional Chinese medicine treatment after surgical treatment

Exclusion criteria

Exclusion criteria: ? Those diagnosed as brain metastasis; ? Those with infectious diseases in the brain; ? Patients diagnosed as lymphoma; ? Other neuroepithelial tumors; ? Those with severe liver and kidney dysfunction; ? Have a history of serious cardiovascular and cerebrovascular diseases; ? Have a history of drug allergy.

Design outcomes

Primary

MeasureTime frame
Progression free survival rate;Disease control rate;

Secondary

MeasureTime frame
Quality of life evaluation;Physical condition evaluation;Neurocognitive function evaluation;Evaluation of Traditional Chinese Medicine Syndrome Type Integral;

Countries

China

Contacts

Public ContactFan Xiaoxuan

Affiliated Hospital of Shaanxi University of Chinese Medicine

szfyfxx@163.com+86 139 9101 6360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026